Trial Profile
Effectiveness of Landiolol for elderly patients at high risk of a cardiovascular event who undergo laparoscopic gastrecomy which potentially induces low cardiac function and tachycardia
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 23 Jun 2020
Price :
$35
*
At a glance
- Drugs Landiolol (Primary)
- Indications Ventricular tachycardia
- Focus Therapeutic Use
- 22 Jun 2020 Status changed from active, no longer recruiting to discontinued.
- 22 Jun 2019 Status changed from recruiting to active, no longer recruiting.
- 20 Jun 2017 Status changed from not yet recruiting to recruiting.